Key result
An injectable capsule system with a low-power photoplethysmography ASIC demonstrated wireless operation in a human subject and in vivo subcutaneous sensing functionality in anesthetized rats.
Why the study?
Deploying photoplethysmography in veterinary medicine has been hindered by light transmission challenges through thick animal skin and fur.
A novel subcutaneously injectable photoplethysmography capsule system demonstrates functional wireless operation and in vivo sensing capabilities in a pilot animal model.
May enable reliable subcutaneous PPG in animals; leaves open safety, efficacy, and adoption pending larger veterinary trials.
Photoplethysmography is an extensively-used, portable, and noninvasive technique for measuring vital parameters such as heart rate, respiration rate, and blood pressure. The deployment of this technology in veterinary medicine has been hindered by the challenges in effective transmission of light presented by the thick layer of skin and fur of the animal. We propose an injectable capsule system to circumvent these limitations by accessing the subcutaneous tissue to enable reliable signal acquisition even with lower light brightness. In addition to the reduction of power usage, the injection of the capsule offers a less invasive alternative to surgical implantation. Our current prototype combines two application-specific integrated circuits (ASICs) with a microcontroller and interfaces with a commercial light emitting diode (LED) and photodetector pair. These ASICs implement a signal-conditioning analog front end circuit and a frequency-shift keying (FSK) transmitter respectively. The small footprint of the ASICs is the key in the integration of the complete system inside a 40-mm long glass tube with an inner diameter of 4 mm, which enables its injection using a custom syringe similar to the ones used with microchip implants for animal identification. The recorded data is transferred wirelessly to a computer for post-processing by means of the integrated FSK transmitter and a software-defined radio. Our optimized LED duty cycle of 0.4% at a sampling rate of 200 Hz minimizes the contribution of the LED driver (only 0.8 mW including the front-end circuitry) to the total power consumption of the system. This will allow longer recording periods between the charging cycles of the batteries, which is critical given the very limited space inside the capsule. In this work, we demonstrate the wireless operation of the injectable system with a human subject holding the sensor between the fingers and the in vivo functionality of the subcutaneous sensing on a pilot study performed on anesthetized rat subjects.
No takes yet. Share an insight, caveat, or question.
Valero-Sarmiento et al. (2020) studied Animal monitoring. Subcutaneously injectable capsule system with photoplethysmography ASIC was evaluated on Wireless operation and in vivo functionality of subcutaneous sensing. An injectable capsule system with a low-power photoplethysmography ASIC demonstrated wireless operation in a human subject and in vivo subcutaneous sensing functionality in anesthetized rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: